Predict your next investment

Venture Capital
FINANCE | Investment Firms & Funds
kurmapartners.com

See what CB Insights has to offer

Investments

79

Portfolio Exits

8

Funds

6

Partners & Customers

1

About Kurma Partners

Kurma Partners is a venture capital firm that focuses on healthcare and biotechnology in Europe. The firm invests at various stages of maturity, from company creation to capital expansion. Kurma Partners brings together, within a network of international alliances, leading European research institutes to be able to identify promising projects in France and Europe. It partners with Cancer Research Technology, Institut Pasteur, and Conectus Alsace.

Kurma Partners Headquarter Location

24, Rue Royale 5e etage

Paris, 75008,

France

+33 (0)1 84 86 08 61

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Kurma Partners

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Kurma Partners in 1 Expert Collection, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Kurma Partners Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Kurma Partners Rank

Latest Kurma Partners News

French digital clinic Charles.co gets a shot of €7 million to make men’s health solutions more accessible

Jun 30, 2022

Tech.eu Tech.eu Insights creates insight and guides strategies with its comprehensive content and reports. Browse popular Insights content. French digital clinic Charles.co gets a shot of €7 million to make men’s health solutions more accessible The men's health clinic will expand its platform beyond sexual health services to include other chronic conditions post the funding Paris-based digital clinic entirely dedicated to men’s health issues, Charles.co has brought in €7 million in a seed-stage funding. The funding will allow the startup to expand its offerings and build out its team, which has already supported 50,000 men in combating chronic conditions such as erectile dysfunction or insomnia. The round was led by Kurma Partners and Speedinvest . Founded in 2019 by Simon Burellier and Olivier Algoud , Charles.co is a digital clinic that addresses chronic health issues in men, such as sexual health, hair loss, or insomnia. The startup offers all its services via an integrated digital platform developed in close collaboration with prominent medical experts on men’s health. The company wants to become the go-to brand for men’s health across Europe. Currently, more than six million men are already using the platform’s medical information each month. As more startups join the race to offer solutions for men’s health, the company is competing with the likes of Numan, which raised $13 million and Manual which raised $30 million last year. Charles.co co-founder Simon Burellier said: “Rapid treatment often means better care, but unfortunately many men feel uncomfortable going for consultations for chronic conditions. The goal of Charles.co is to reconnect men with their health and to offer them a safe, easily accessible space where they can get information, consult remotely and receive complete support for their medical issues.” Benjamin Belot , associate director at Kurma Partners added: “Given the shortage of specialists for men’s health, Charles.co is offering men a new way to access healthcare for some of their most sensitive problems, allowing them a confidential and effective treatment route.”

Kurma Partners Investments

79 Investments

Kurma Partners has made 79 investments. Their latest investment was in Ermium Therapeutics as part of their Series A - II on June 6, 2022.

CBI Logo

Kurma Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/30/2022

Series A - II

Ermium Therapeutics

$6.29M

No

2

6/30/2022

Seed VC

Charles

$7.28M

Yes

1

6/13/2022

Series C

ImCheck Therapeutics

$103M

No

4

5/10/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

2/4/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/30/2022

6/30/2022

6/13/2022

5/10/2022

2/4/2022

Round

Series A - II

Seed VC

Series C

Series A

Series A

Company

Ermium Therapeutics

Charles

ImCheck Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$6.29M

$7.28M

$103M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

4

10

10

Kurma Partners Portfolio Exits

8 Portfolio Exits

Kurma Partners has 8 portfolio exits. Their latest portfolio exit was Cardiologs on November 08, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/8/2021

Acquired

$99M

4

11/5/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

6/22/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

2/5/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

1/22/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/8/2021

11/5/2021

6/22/2021

2/5/2021

1/22/2020

Exit

Acquired

IPO

Acquired

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

4

10

10

10

10

Kurma Partners Fund History

6 Fund Histories

Kurma Partners has 6 funds, including Kurma Growth Opportunities Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

3/8/2022

Kurma Growth Opportunities Fund

$174.54M

1

12/8/2021

Kurma Diagnostics 2

$99M

10

4/30/2020

Kurma Biofund III

$99M

10

5/26/2015

Kurma Diagnostics

$99M

10

Kurma Biofund I

0

Closing Date

3/8/2022

12/8/2021

4/30/2020

5/26/2015

Fund

Kurma Growth Opportunities Fund

Kurma Diagnostics 2

Kurma Biofund III

Kurma Diagnostics

Kurma Biofund I

Fund Type

Status

Amount

$174.54M

$99M

$99M

$99M

Sources

1

10

10

10

0

Kurma Partners Partners & Customers

1 Partners and customers

Kurma Partners has 1 strategic partners and customers. Kurma Partners recently partnered with Heidelberg Pharma on November 11, 2019.

Kurma Partners Team

3 Team Members

Kurma Partners has 3 team members, including current Managing Partner, Thierry Laugel.

Name

Work History

Title

Status

Thierry Laugel

Managing Partner

Current

Remi Droller

Managing Director

Current

Alain Maiore

Founder

Former

Name

Thierry Laugel

Remi Droller

Alain Maiore

Work History

Title

Managing Partner

Managing Director

Founder

Status

Current

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.